| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 338 / 428 | 21st | Q4 |
| Cancer Research | 203 / 233 | 13th | Q4 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
South Asian Journal of Cancer
South Asian Journal of Cancer is Scopus-indexed (Q4, CiteScore 1), WoS ESCI, DOAJ. Published by Georg Thieme Verlag.
Checked against the index lists dated .
ISSN 2278-330XVerify ISSN ↗2278-4306Verify ISSN ↗
Publisher: Georg Thieme Verlag
Cost to publish: Checking DOAJ for article charges…
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is South Asian Journal of Cancer indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2012–2025, best quartile Q4, CiteScore 1.
What quartile is South Asian Journal of Cancer in Scopus?
South Asian Journal of Cancer is Q4 in Oncology (rank 338 of 428) and Q4 in Cancer Research (rank 203 of 233), by CiteScore 2025.
What is the impact factor of South Asian Journal of Cancer?
South Asian Journal of Cancer is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1, which places it in quartile Q4 at the 21st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.307, quartile Q3, with an H-index of 30.
Who publishes South Asian Journal of Cancer and what is its ISSN?
South Asian Journal of Cancer is published by Georg Thieme Verlag. Its print ISSN is 2278-330X and its online ISSN is 2278-4306.
Is South Asian Journal of Cancer in Web of Science?
Yes — indexed in the Emerging Sources Citation Index.
Is South Asian Journal of Cancer open access?
Yes — it is an open-access journal, listed in DOAJ.
How well cited is South Asian Journal of Cancer? — open metrics via OpenAlex
South Asian Journal of Cancer has an h-index of 43 and a 2-year mean of 0.67 citations per paper (OpenAlex). Its Scopus CiteScore is 1, quartile Q4. On 2-year citations it ranks #315 of 424 Scopus journals in Oncology.
South Asian Journal of Cancer published 37 papers in 2025; its busiest recent year was 2024 with 109. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in South Asian Journal of Cancer? — latest 95 articles, 2024–2026
In its latest 95 research articles (2024–2026), authors are most often from India (79.5%), United States (4.2%) and Bangladesh (3.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for South Asian Journal of Cancer? — indicators, not proof of misconduct
Scopus status: Active. 2 retracted papers are recorded (1.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 2 · 1.7 per 1,000 papers
- Problematic Paper Screener flags None flagged
- Author concentration79.5% of recent authorship from India
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.